Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kelsey Sharkey"'
Autor:
Kelsey Sharkey, Peter T. Beernink, Joanne M. Langley, Soren Gantt, Caroline Quach, Christina Dold, Qin Liu, Manuel Galvan, Dan M. Granoff
Publikováno v:
mSphere, Vol 4, Iss 4 (2019)
ABSTRACT Meningococcal serogroup B (MenB) vaccines contain recombinant factor H binding protein (FHbp), which can complex with complement factor H (CFH) and thereby risk eliciting anti-FH autoantibodies. While anti-FH antibodies can be present in ser
Externí odkaz:
https://doaj.org/article/9530d107fca64058aee7613a681cc7e6
Autor:
Manuel Galvan, Joanne M. Langley, Peter T. Beernink, Caroline Quach, Kelsey Sharkey, Dan M. Granoff, Qin Liu, Soren Gantt, Christina Dold
Publikováno v:
mSphere
mSphere, Vol 4, Iss 4 (2019)
mSphere, Vol 4, Iss 4 (2019)
Meningococci are bacteria that cause sepsis and meningitis. Meningococcal species are subdivided into serogroups on the basis of different sugar capsules. Vaccines that target serogroup A, C, Y, and W capsules are safe and highly effective. New serog
Autor:
Flor A. Gowans, Eduardo Lujan, Peter T. Beernink, Dan M. Granoff, Serena Giuntini, Kelsey Sharkey
Meningococcal factor H-binding protein (FHbp) is an antigen in 2 serogroup B meningococcal vaccines. FHbp specifically binds human and some nonhuman primate complement FH. To investigate the effect of binding of FH to FHbp on protective antibody resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b47e5cbb6243b326d31f8540e06acbe
https://europepmc.org/articles/PMC5033880/
https://europepmc.org/articles/PMC5033880/